✦ LIBER ✦

Identification of a polypeptide secreted by human breast cancer cells (MCF-7) as the human estrogen-responsive gene (pS2) product

✍ Scribed by Kazutoshi Mori; Ritsuko Fujii; Noriyoshi Kida; Mitsuhiro Ohta; Kyozo Hayashi

Book ID: 117058532
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 379 KB
Volume: 155
Category: Article
ISSN: 0006-291X
DOI: 10.1016/s0006-291x(88)81094-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogenic effects of nonylphenol on pS2

Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7

✍ Lifen Ren; Melissa A. Marquardt; John J. Lech 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 777 KB

Regulation of keratin 19 gene expression

Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region

✍ Inho Choi; Lorraine J Gudas; Benita S Katzenellenbogen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Identification and characterization of a

Identification and characterization of a phytoestrogen-specific gene from the MCF-7 human breast cancer cell

✍ Lakshmi Ramanathan; Wesley G Gray 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 539 KB

Estrogen-inducible pS2 protein is not th

Estrogen-inducible pS2 protein is not the key regulatory component in the proliferation of human breast cancer cells (MCF-7)

✍ Noriyoshi KIDA; Tomoaki YOSHIMURA; Haruo TAKAHASHI; Seiji NAGAO; Yoshinori NOZAW 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

The 5′ flanking region of the human pS2

The 5′ flanking region of the human pS2 gene mediates its transcriptional activation by estrogen in MCF-7 cells

✍ Margo Roberts; John Wallace; Jean-Marc Jeltsch; Meera Berry 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 757 KB

Identification of a novel breast-cancer-

Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells

✍ Lambert C.J. Dorssers; Jos Veldscholte 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 177 KB 👁 2 views

Development of anti-estrogen resistance limits the benefit of endocrine therapy of breast cancer. The mechanistic basis for resistance to the anti-estrogen tamoxifen may involve (epi)genetic alterations within tumor cells. We have initiated a random search for genes allowing estrogen-dependent ZR-75